Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been assigned an average rating of “Hold” from the twenty-two research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and eleven have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $72.37.
TEM has been the subject of several research analyst reports. Roth Capital started coverage on Tempus AI in a research report on Tuesday, September 8th. They set a “neutral” rating and a $67.00 target price for the company. Cantor Fitzgerald assumed coverage on shares of Tempus AI in a research note on Wednesday, September 2nd. They set an “overweight” rating and a $80.00 price target for the company. HC Wainwright boosted their price target on Tempus AI from $56.00 to $66.00 and gave the company a “buy” rating in a report on Friday, September 11th. Piper Sandler upgraded Tempus AI from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $56.00 to $76.00 in a report on Tuesday, September 1st. Finally, JPMorgan Chase & Co. increased their price objective on Tempus AI from $45.00 to $70.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 14th.
Read Our Latest Stock Analysis on Tempus AI
Tempus AI Price Performance
Tempus AI stock opened at $64.72 on Monday. The firm has a 50-day moving average price of $68.07 and a 200-day moving average price of $56.58. The firm has a market capitalization of $11.68 billion, a PE ratio of -44.94 and a beta of 3.54. The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06. Tempus AI has a 12-month low of $40.77 and a 12-month high of $96.29.
Tempus AI (NASDAQ:TEM – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to the consensus estimate of $379.69 million. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The firm’s revenue was up 21.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.22) EPS. As a group, equities research analysts forecast that Tempus AI will post -1.38 EPS for the current year.
Insider Buying and Selling at Tempus AI
In other Tempus AI news, EVP Andrew Polovin sold 22,148 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $49.61, for a total transaction of $1,098,762.28. Following the completion of the sale, the executive vice president owned 146,067 shares in the company, valued at $7,246,383.87. This represents a 13.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Ryan Fukushima sold 41,095 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $49.61, for a total value of $2,038,722.95. Following the sale, the chief executive officer owned 562,463 shares of the company’s stock, valued at $27,903,789.43. This trade represents a 6.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 1,280,965 shares of company stock worth $80,397,564. Company insiders own 24.26% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the company. V Square Quantitative Management LLC acquired a new position in shares of Tempus AI during the third quarter valued at about $27,000. Cyndeo Wealth Partners LLC boosted its stake in Tempus AI by 6.7% in the 3rd quarter. Cyndeo Wealth Partners LLC now owns 6,412 shares of the company’s stock worth $525,000 after purchasing an additional 400 shares in the last quarter. Arkadios Wealth Advisors grew its position in Tempus AI by 9.6% during the 1st quarter. Arkadios Wealth Advisors now owns 4,963 shares of the company’s stock worth $224,000 after purchasing an additional 435 shares during the last quarter. GAMMA Investing LLC grew its position in Tempus AI by 54.3% during the 3rd quarter. GAMMA Investing LLC now owns 1,239 shares of the company’s stock worth $101,000 after purchasing an additional 436 shares during the last quarter. Finally, EMC Capital Management acquired a new stake in shares of Tempus AI during the second quarter worth $29,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.
About Tempus AI
Tempus AI, Inc is a technology company focused on applying artificial intelligence and data analytics to precision medicine. The company develops tools intended to help physicians make more informed treatment decisions by combining clinical information, molecular data and other health-related datasets.
Tempus provides genomic testing and diagnostic services, including sequencing and other molecular tests used primarily in oncology. Its platform also offers data and software solutions designed to support clinical research, pharmaceutical development, patient identification for clinical trials and the development of personalized treatment strategies.
Founded in 2015, Tempus is headquartered in Chicago and primarily serves healthcare providers, researchers and life sciences companies.
Read More
- Five stocks we like better than Tempus AI
- These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
- Meta Claims Frontier-Class AI Status With New Muse Wonder Models
- Berkshire Just Backed This Little-Known Stock—Should You Chase It?
- Broadcom’s CEO Sees Years of AI Demand But Warns of a Bigger Threat to the Boom
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
